Latest Breaking News On - Company expects to achieve positive adjusted - Page 1 : comparemela.com

IM Cannabis Reports Record First Quarter 2022 Financial Results; Revenues Increase 169% YoY to $23.6 Million. Gross Profit Increased 37% from Q1 2021 as Operational. #imcannabis #IMCHoldings #imcc

Israel generalUnited statesVironna pharmOren shusterSde avrahamAdjupharm gmbhPharm yarokHerbs ltdRosen high way ltdIsraeli medical cannabis agencyCompany expects to achieve positive adjustedPanaxia labs israel ltdNutraceuticals incInternational financial reporting standardsIm cannabis corpAcquisition corp